Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Analyze when to tilt toward stocks or bonds in retirement. A practical guide to selecting the right index mix for your goals.
22,201 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Shiba Inu token eyes a decisive price move as on-chain data hints at a potential breakout, even as Shibarium shows si...
Investors are buzzing about The Metals Company as a potential new source of critical minerals. This article weighs th...
A major investor sold a substantial stake in an Ethereum ETF, pulling out nearly $19 million in one trade. The move r...
If Rivian hits the sweet spot with the R2, the stock story could change in meaningful ways. This guide breaks down wh...
Palantir stock slides further from its 52-week high even after a standout Q4, as investors weigh a rich valuation aga...
As federal agencies debate when a car becomes a weapon, lawmakers and taxpayers face rising costs, lawsuits, and ques...
The administration signals a possible tanker escort plan through the Strait of Hormuz, but says the Navy isn’t ready....
As AMD gears up for its Aug. 4 earnings release, the stock’s unstoppable momentum raises questions: what would truly ...
Two AI powerhouses are forming a rare alliance to chase a massive market. This article explains the rationale, potent...
Federal prosecutors say a California couple ran a crypto-laundering operation tied to darknet fentanyl shipments, mov...
A fresh, no-copy analysis of Joint (JYNT) 2025 earnings, focusing on Q4 results, margin trends, and the roadmap for 2...